Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Capsicum frutescens is a species of chili pepper, including varieties such as malagueta and bird's eye chili, widely utilized as a spice, dietary supplement, and in traditional medicine. Its primary bioactive constituents are capsaicinoids (notably capsaicin), which function as potent agonists of the Transient Receptor Potential Vanilloid 1 (TRPV1) channel, influencing thermoregulation and pain perception. Clinical research has explored homeopathic preparations of C. frutescens for the relief of menopausal hot flushes, based on the principle of "like cures like." Additionally, the plant contains antimicrobial peptides known as lipid transfer proteins (LTPs) with antifungal properties against Candida species, and its extracts have shown antioxidant and antiplasmodial activity in preclinical models of malaria. It is also used in ethnoveterinary practices for treating various poultry diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on capsicum frutescens.